Sunday, March 27, 2011

Clinical Workflow Study For Evaluation Of Multi-electrode Pulmonary Vein Isolation System For Treatment Of Paroxysmal Atrial Fibrillation

Biosense Webster, Inc., a Johnson & Johnson company, and a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announced enrollment commencement of the REVOLUTION Study (Clinical WoRkflow Study for the EValuation Of the Multi-ELectrode PUlmonary Vein Isolation System for the Treatment of Paroxysmal AtrIal FibrillatiON)...

Psychiatry Staying Healthy Stress health

No comments:

Post a Comment